Get the app!
Back to Trades

Hallett David

Chief Scientific OfficerCIK 0002006495

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
5
Buy transactions
0
Sell transactions
0
Companies
1
Active
2026

Hallett David, Chief Scientific Officer, has filed 5 SEC reports (2026), all concentrated in RECURSION PHARMACEUTICALS, INC. (RXRX), totaling $337.1K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

5 loaded
Nov 18RXRX
RECURSION PHARMACEUTICALS, INC.
Hallett DavidChief Scientific OfficerTax withheld$84.9K
Aug 18RXRX
RECURSION PHARMACEUTICALS, INC.
Hallett DavidChief Scientific OfficerTax withheld$84.2K
May 19RXRX
RECURSION PHARMACEUTICALS, INC.
Hallett DavidChief Scientific OfficerTax withheld$81.0K
Feb 19RXRX
RECURSION PHARMACEUTICALS, INC.
Hallett DavidChief Scientific OfficerTax withheld$41.6K
Feb 10RXRX
RECURSION PHARMACEUTICALS, INC.
Hallett DavidChief Scientific OfficerGrant$45.4K

5 filings